| Product Code: ETC9690783 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Oligonucleotide Therapeutics Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Oligonucleotide Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Oligonucleotide Therapeutics Market - Industry Life Cycle |
3.4 Thailand Oligonucleotide Therapeutics Market - Porter's Five Forces |
3.5 Thailand Oligonucleotide Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Thailand Oligonucleotide Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Thailand Oligonucleotide Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Thailand |
4.2.2 Growing investments in healthcare infrastructure and research development |
4.2.3 Rising demand for personalized medicine in the region |
4.3 Market Restraints |
4.3.1 Stringent regulations and approvals process for oligonucleotide therapeutics |
4.3.2 High costs associated with research, development, and manufacturing of oligonucleotide therapeutics |
5 Thailand Oligonucleotide Therapeutics Market Trends |
6 Thailand Oligonucleotide Therapeutics Market, By Types |
6.1 Thailand Oligonucleotide Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Oligonucleotide Therapeutics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Thailand Oligonucleotide Therapeutics Market Revenues & Volume, By Antisense, 2021- 2031F |
6.1.4 Thailand Oligonucleotide Therapeutics Market Revenues & Volume, By Ribozymes, 2021- 2031F |
6.1.5 Thailand Oligonucleotide Therapeutics Market Revenues & Volume, By Aptamers, 2021- 2031F |
6.1.6 Thailand Oligonucleotide Therapeutics Market Revenues & Volume, By Mirna, 2021- 2031F |
6.1.7 Thailand Oligonucleotide Therapeutics Market Revenues & Volume, By Cpg/Immunostimulatory, 2021- 2031F |
6.1.8 Thailand Oligonucleotide Therapeutics Market Revenues & Volume, By RNAi, 2021- 2031F |
6.2 Thailand Oligonucleotide Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Thailand Oligonucleotide Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.3 Thailand Oligonucleotide Therapeutics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.4 Thailand Oligonucleotide Therapeutics Market Revenues & Volume, By Neurodegenerative Disorders, 2021- 2031F |
6.2.5 Thailand Oligonucleotide Therapeutics Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.2.6 Thailand Oligonucleotide Therapeutics Market Revenues & Volume, By Kidney Diseases, 2021- 2031F |
6.2.7 Thailand Oligonucleotide Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 Thailand Oligonucleotide Therapeutics Market Import-Export Trade Statistics |
7.1 Thailand Oligonucleotide Therapeutics Market Export to Major Countries |
7.2 Thailand Oligonucleotide Therapeutics Market Imports from Major Countries |
8 Thailand Oligonucleotide Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials conducted for oligonucleotide therapeutics in Thailand |
8.2 Adoption rate of oligonucleotide therapeutics by healthcare providers in the region |
8.3 Amount of funding allocated towards oligonucleotide therapeutics research and development in Thailand |
9 Thailand Oligonucleotide Therapeutics Market - Opportunity Assessment |
9.1 Thailand Oligonucleotide Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Thailand Oligonucleotide Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Thailand Oligonucleotide Therapeutics Market - Competitive Landscape |
10.1 Thailand Oligonucleotide Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Thailand Oligonucleotide Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here